GlassScriptPhysician profile
Evangeline G Perez
NPI 1891761334
$9,436.20
in general payments reported to CMS, 2019-2025
37 companies · $2,576 in 2025
The $2,576 reported for 2025 was more than what 82% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $716 · 2020: $505 · 2021: $991 · 2022: $997 · 2023: $1,592 · 2024: $2,060 · 2025: $2,576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,014 · Education: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,013.81 |
| Education | $214.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,583.69 | 2019-2025 | |
| Pfizer INC. | $1,137.96 | 2019-2025 | |
| Dermavant Sciences, INC. | $814.12 | 2022-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $734.13 | 2023-2025 | Zoryve |
| Incyte Corporation | $728.53 | 2021-2025 | Opzelura |
| Janssen Biotech, INC. | $675.77 | 2023-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $634.34 | 2020-2025 | Ilumya, Winlevi |
| Lilly USA, LLC | $342.54 | 2019-2025 | Ebglyss, Olumiant, Taltz |
| Vyne Pharmaceuticals INC. | $320.43 | 2020-2021 | |
| Galderma Laboratories, L.P. | $307.93 | 2019-2025 | Twyneo, Aklief, Oracea |
| Amgen INC. | $285.78 | 2020-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $276.87 | 2021-2025 | |
| Genzyme Corporation | $247.32 | 2021-2025 | |
| Ucb, INC. | $241.11 | 2025 | Bimzelx |
| Leo Pharma INC. | $168.44 | 2019-2025 | Anzupgo, Adbry |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $128.85 | 2025 | Vtama |
| Regeneron Healthcare Solutions, INC. | $116.30 | 2022-2025 | Dupixent |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $110.02 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $91.13 | 2024-2025 | |
| Epi Health, LLC | $64.34 | 2019-2022 | |
| Genentech USA, INC. | $56.42 | 2022-2025 | Xolair |
| Sebela Pharmaceuticals INC. | $52.82 | 2019-2023 | Naftin, Pramosone |
| Lnhc, INC | $37.40 | 2025 | Zelsuvmi |
| E.R. Squibb & Sons, L.L.C. | $36.55 | 2023-2024 | Sotyktu |
| Almirall LLC | $35.40 | 2021 | |
| Strata Skin Sciences, INC. | $30.37 | 2023-2025 | Xtrac |
| Journey Medical Corporation | $22.66 | 2024 | |
| Verrica Pharmaceuticals INC. | $21.66 | 2024 | Ycanth |
| Biofrontera INC. | $19.77 | 2021 | |
| Promius Pharma LLC | $18.22 | 2019 | |
| Prugen, INC. Pharmaceuticals | $15.80 | 2019 | |
| Aclaris Therapeutics, INC. | $15.31 | 2019 | |
| Celgene Corporation | $13.99 | 2019 | |
| Merck Sharp & Dohme LLC | $13.42 | 2019 | |
| Encore Dermatology INC. | $13.40 | 2019 | |
| Dermira, INC. | $12.21 | 2019 | |
| Mission Pharmacal Company | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evangeline Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.